Hemispherx BioPharma Inc. (HEB) Fell -9.13% or -0.02 To Price $0.23 On Friday


Hemispherx BioPharma Inc. (HEB) fell -9.13% or -0.02 to $0.23. It is around 346269 shares traded, which is 210.24% compare to the average total volume 164698. The market cap of HEB is $10.86 million. The year to date change is -35.8%. The 52 week price range is from $0.15 to $0.65. Price of HEB have changed -2.69% during last week. It have changed -14.35% over last month, -17.05% over last 3 months, -49.34% over last 6 months and -20.94% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HEB is 0.29. It is 26.09% above current price. The 200-day Moving Averages for HEB is 0.37. It is 60.87% above current price. The 52-week High is 0.65. It is 182.61% from the current price. The 52-week Low is 0.15. It is -34.78% from current price.

There are some statistics of HEB. It is has market cap $10.86 million. The share outstanding is 47.25 million. The average volume is 164698. The percent of top 15 Institution holding is 2.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HEB is -85.17%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HEB is -52.07%.


Tags:

Share this post